Zura Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Cash & Equivalents	154.49	176.5	99.81	1.57	4.72
Cash & Short-Term Investments	154.49	176.5	99.81	1.57	4.72
Cash Growth	-18.02%	76.84%	6269.24%	-66.80%	-
Prepaid Expenses	2.5	2.25	1.04	0.21	-
Total Current Assets	156.99	178.74	100.84	1.78	4.72
Property, Plant & Equipment	0.12	0.09	-	-	-
Long-Term Deferred Charges	-	-	-	3.49	-
Other Long-Term Assets	0.7	0.7	-	-	-
Total Assets	157.81	179.53	100.84	5.26	4.72
Accounts Payable	1.21	0.73	2.75	2.01	0.01
Accrued Expenses	12.49	9.28	7.55	0.82	-
Short-Term Debt	-	-	-	7.76	-
Other Current Liabilities	5	9.5	10	4.23	0.03
Total Current Liabilities	18.7	19.51	20.3	14.82	0.04
Other Long-Term Liabilities	-	-	0.99	-	-
Total Liabilities	18.7	19.51	21.29	14.82	0.04
Common Stock	0.01	0.01	0	-	-
Additional Paid-In Capital	315.23	302.71	162.82	-	-
Retained Earnings	-189.33	-155.9	-103.49	-32.06	-7.82
Total Common Equity	125.91	146.82	59.33	-32.06	-7.82
Minority Interest	13.2	13.2	20.22	10	-
Shareholders' Equity	139.11	160.02	79.55	-9.56	4.68
Total Liabilities & Equity	157.81	179.53	100.84	5.26	4.72
Total Debt	-	-	-	7.76	-
Net Cash (Debt)	154.49	176.5	99.81	-6.19	4.72
Net Cash Growth	-18.02%	76.84%	-	-	-
Net Cash Per Share	1.69	2.35	3.02	-27.13	-
Filing Date Shares Outstanding	65.02	68.37	43.59	43.09	17.25
Total Common Shares Outstanding	62.06	65.3	43.59	0.38	17.25
Working Capital	138.29	159.23	80.54	-13.04	4.68
Book Value Per Share	2.03	2.25	1.36	-83.59	-0.45
Tangible Book Value	125.91	146.82	59.33	-32.06	-7.82
Tangible Book Value Per Share	2.03	2.25	1.36	-83.59	-0.45

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q